General MedicationsORALGeneric

LEVOTHYROXINE SODIUM

Standard Dose

0.137MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Discontinued

Summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 211369 (ANDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient LEVOTHYROXINE SODIUM Form and strength CAPSULE;ORAL - 0.137MG Sponsor ANI PHARMS Submission history Latest submission status date: 2023-05-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 211369 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient LEVOTHYROXINE SODIUM Form and strength CAPSULE;ORAL - 0.137MG Sponsor ANI PHARMS Submission history Latest submission status date: 2023-05-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.